New location brings laboratory services closer to Metropolitan area physicians
Rye Brook, N.Y. (PRWEB) May 28, 2009 -- CBLPath, Inc., one of the nation's fastest-growing providers of specialized anatomic pathology services, today announced the opening of its Manhattan Facility as part of the company's continuous effort to enhance services for Metropolitan area physicians. Licensed by the New York State Department of Health (NYSDOH), the new facility is located at 400 East 66th Street, Suite 2D, and augments CBLPath's state-of-the-industry 66,000-square-foot main laboratory facility, which is located at 760 Westchester Avenue in Rye Brook, N.Y.
"We're very pleased to be able to bring our laboratory services closer to our physician-clients' practices," said Madeline Vazquez, M.D., Associate Director of the Manhattan Facility.
To find out more about the CBLPath Manhattan Facility, contact the company's Client Services Department or your local sales and service representative at 877.CBLPath (877.225.7284).
CBLPath, Inc. is a landmark anatomic pathology laboratory that delivers state-of-the-industry diagnostic testing and innovative technology solutions to its physician-clients across the nation. Founded in 1988 as Cytopath Biopsy Lab, CBLPath quickly established a reputation for providing timely and highly accurate diagnoses along with extraordinary customer service and a true patient-centered commitment. Additional information about the company is available by visiting CBLPath.com.
This news release may contain forward-looking statements (as delineated in the Private Securities Litigation Reform Act of 1995), which are based on the expectations, projections and beliefs of company management at the time of pronouncement. Some forward-looking statements may be identified by the use of such terms as "believes," "anticipates," "may," "intends," "plans," "estimates," "projects" and "expects." The company takes no obligation to update or revise any such statements after the date on which they are made. Forward-looking statements are subject to a wide range of risks and uncertainties that can cause actual results to differ materially from anticipated results. These variable factors include, but are not limited to, operating initiatives and acquisitions, general economic conditions, the competitive environment, federal and state laws and regulations (and changing interpretations thereof), reimbursement rates under government and third party healthcare programs and unanticipated expenditures. Accordingly, no assurance can be given as to the future financial condition, cash flow or results of operations of the company or any of its businesses. Further information regarding factors that could cause the company's results to differ from expectations is included in its annual reports.
Read the full story at http://www.prweb.com/releases/2009/05/prweb2462804.htm.
Copyright©2009 Vocus, Inc.
All rights reserved